Publications by the researcher in collaboration with Olatz Garin (17)

2024

  1. Erratum: Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after (Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2023) 32 4 (989-1003))

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

2023

  1. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

    Quality of Life Research, Vol. 32, Núm. 4, pp. 989-1003

2018

  1. Validity of the EQ–5D–5L and reference norms for the Spanish population

    Quality of Life Research, Vol. 27, Núm. 9, pp. 2337-2348

2016

  1. Economic evaluation of health services costs during pandemic influenza a (H1N1) Pdm09 infection in pregnant and non-pregnant women in Spain

    Iranian Journal of Public Health, Vol. 45, Núm. 4, pp. 423-434

  2. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

2014

  1. Pandemic influenza A (H1N1) in non-vaccinated, pregnant women in Spain (2009-2010)

    Maternal and Child Health Journal, Vol. 18, Núm. 6, pp. 1454-1461

  2. Pandemic influenza a (H1N1) infection in pregnant and nonpregnant women in Spain (2009-2010)

    Japanese Journal of Infectious Diseases, Vol. 67, Núm. 3, pp. 163-171

  3. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: A case-control study

    Pediatric Infectious Disease Journal, Vol. 32, Núm. 4, pp. 330-334

  2. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons

    Human Vaccines and Immunotherapeutics, Vol. 9, Núm. 4, pp. 865-873

  3. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza

    Clinical Infectious Diseases, Vol. 57, Núm. 2, pp. 167-175

  4. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

  5. Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic

    BMC Public Health, Vol. 13, Núm. 1

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

  3. Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 10, pp. 2693-2701

  4. Sociodemographic factors and clinical conditions associated to hospitalization in influenza a (H1N1) 2009 virus infected patients in spain, 2009-2010

    PLoS ONE, Vol. 7, Núm. 3